Potent inhibition of a GH20 exo-β-N-acetylglucosaminidase from marine Vibrio bacteria by reaction intermediate analogues

Suginta, 2010, Novel β-N-acetylglucosaminidases from Vibrio harveyi 650: cloning, expression, enzymatic properties, and subsite identification, BMC Biochem., 11, 40, 10.1186/1471-2091-11-40 Thi, 2014, Structure and activity of the Streptomyces coelicolor A3(2) β-N-acetylhexosaminidase provides further insight into GH20 family catalysis and inhibition, Biochemistry, 53, 1789, 10.1021/bi401697j Zhou, 2017, A Shinella β-N-acetylglucosaminidase of glycoside hydrolase family 20 displays novel biochemical and molecular characteristics, Extremophiles, 21, 699, 10.1007/s00792-017-0935-1 Davies, 1995, Structures and mechanisms of glycosyl hydrolases, Structure, 3, 853, 10.1016/S0969-2126(01)00220-9 Gebler, 1992, Stereoselective hydrolysis catalyzed by related β-1,4-glucanases and β-1,4-xylanases, J. Biol. Chem., 267, 12559, 10.1016/S0021-9258(18)42313-7 Vocadlo, 2000, Mechanism of action and identification of Asp242 as the catalytic nucleophile of Vibrio furnisii N-acetyl-β-d-glucosaminidase using 2-acetamido-2-deoxy-5-fluoro-α-l-idopyranosyl fluoride, Biochemistry, 39, 117, 10.1021/bi991958d Vocadlo, 2005, Detailed comparative analysis of the catalytic mechanisms of β-N-acetylglucosaminidases from families 3 and 20 of glycoside hydrolases, Biochemistry, 44, 12809, 10.1021/bi051121k Drouillard, 1997, Serratia marcescens chitobiase is a retaining glycosidase utilizing substrate acetamido group participation, Biochem. J., 328, 945, 10.1042/bj3280945 Mark, 2001, Crystallographic evidence for substrate-assisted catalysis in a bacterial β-hexosaminidase, J. Biol. Chem., 276, 10330, 10.1074/jbc.M011067200 Rao, 2006, Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis, EMBO J., 25, 1569, 10.1038/sj.emboj.7601026 Robbins, 1992, Cloning and high-level expression of chitinase-encoding gene of Streptomyces plicatus, Gene, 111, 69, 10.1016/0378-1119(92)90604-N Sandhoff, 1998, Processing of sphingolipid activator proteins and the topology of lysosomal digestion, Acta Biochim. Pol., 45, 373, 10.18388/abp.1998_4232 Gravel, 1995, The GM2 gangliosidoses, 1807 Myerowitz, 1997, Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene, Hum. Mutat., 9, 195, 10.1002/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.0.CO;2-7 Yuzwa, 2014, O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond, Chem. Soc. Rev., 43, 6839, 10.1039/C4CS00038B Ma, 2013, Protein O-GlcNAcylation in diabetes and diabetic complications, Expert Rev. Proteomics, 10, 365, 10.1586/14789450.2013.820536 Vaidyanathan, 2014, Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes, J. Biol. Chem., 289, 34466, 10.1074/jbc.R114.591560 Ferrer, 2016, O-GlcNAcylation in cancer biology: linking metabolism and signaling, J. Mol. Biol., 428, 3282, 10.1016/j.jmb.2016.05.028 Singh, 2015, O-GlcNAc signaling in cancer metabolism and epigenetics, Cancer Lett., 356 (, 244, 10.1016/j.canlet.2014.04.014 Furneaux, 1994, The chemistry of castanospermine, part I: synthetic modifications at C-6, Tetrahedron, 50, 2131, 10.1016/S0040-4020(01)85075-4 Kappes, 1989, Synthesis and inhibitory properties of 2-acetamido-2-deoxynojirimycin (2-acetamido-5-amino-2,5-dideoxy-d-glucopyranose, 1) and 2-acetamido-1,2-dideoxynojirimycin (2-acetamido-1,5-imino-1,2,5-trideoxy-d-glucitol, 2), J. Carbohydr. Chem., 8, 371, 10.1080/07328308908048567 Knapp, 1996, NAG-thiazoline, an N-acetyl-β-hexosaminidase inhibitor that implicates acetamido participation, J. Am. Chem. Soc., 118, 6804, 10.1021/ja960826u Stubbs, 2006, A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase, Org. Biomol. Chem., 4, 839, 10.1039/b516273d Tropak, 2004, Pharmacological enhancement of β-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff patients, J. Biol. Chem., 279, 13478, 10.1074/jbc.M308523200 Macauley, 2005, O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors, J. Biol. Chem., 280, 25313, 10.1074/jbc.M413819200 Stubbs, 2007, Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated β-lactam resistance, J. Biol. Chem., 282, 21382, 10.1074/jbc.M700084200 Dennis, 2006, Structure and mechanism of a bacterial β-glucosaminidase having O-GlcNAcase activity, Nat. Struct. Mol. Biol., 13, 365, 10.1038/nsmb1079 Dong, 1994, Purification and characterization of an O-GlcNAc selective N-acetyl-β-d-glucosaminidase from rat spleen cytosol, J. Biol. Chem., 269, 19321, 10.1016/S0021-9258(17)32170-1 Sumida, 2012, Gaining insight into the inhibition of glycoside hydrolase family 20 exo-β-N-acetylhexosaminidases using a structural approach, Org. Biomol. Chem., 10, 2607, 10.1039/c2ob06636j Bateman, 2011, Crystal structure of β-hexosaminidase B in complex with pyrimethamine, a potential pharmacological chaperone, J. Med. Chem., 54, 1421, 10.1021/jm101443u Meekrathok, 2016, Probing the catalytic mechanism of Vibrio harveyi GH20 β-N-acetylglucosaminidase by chemical rescue, PLoS One, 11, 10.1371/journal.pone.0149228 Sirimontree, 2016, Azide anions inhibit GH-18 endochitinase and GH-20 exo β-N-acetylglucosaminidase from the marine bacterium Vibrio harveyi, J. Biochem., 159, 191, 10.1093/jb/mvv087 Austin, 2006, Vibrio harveyi: a significant pathogen of marine vertebrates and invertebrates, Lett. Appl. Microbiol., 43, 119, 10.1111/j.1472-765X.2006.01989.x Lemieux, 2006, Crystallographic structure of human β-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis, J. Mol. Biol., 359, 913, 10.1016/j.jmb.2006.04.004 Meekrathok, 2015, Expression, purification, crystallization and preliminary crystallographic analysis of a GH20 β-N-acetylglucosaminidase from the marine bacterium Vibrio harveyi, Acta Crystallogr. Sect. F, 71, 427, 10.1107/S2053230X1500415X Gill, 1989, Calculation of protein extinction coefficients from amino acid sequence data, Anal. Biochem., 182, 319, 10.1016/0003-2697(89)90602-7 Goddard-Borger, 2010, An improved route to PUGNAc and its galacto-configured congener, J. Organomet. Chem., 75, 3931, 10.1021/jo100614b Stubbs, 2013, The development of selective inhibitors of NagZ: increased susceptibility of Gram-negative bacteria to β-lactams, Chembiochem, 14, 1973, 10.1002/cbic.201300395 Zakariassen, 2007, Heat capacity changes in heme protein-ligand interactions, Thermochim. Acta, 464, 24, 10.1016/j.tca.2007.07.021 Murphy, 1994, Entropy in biological binding processes: estimation of translational entropy loss, Proteins, 18, 63, 10.1002/prot.340180108 Miller, 1959, Use of dinitrosalicylic acid reagent for determination of reducing sugar, Anal. Chem., 31, 426, 10.1021/ac60147a030 Verdonk, 2003, Improved protein-ligand docking using GOLD, Proteins, 52, 609, 10.1002/prot.10465 Tews, 1996, Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease, Nat. Struct. Biol., 3, 638, 10.1038/nsb0796-638 Suginta, 2004, An endochitinase A from Vibrio carchariae: cloning, expression, mass and sequence analyses, and chitin hydrolysis, Arch. Biochem. Biophys., 424, 171, 10.1016/j.abb.2004.01.017 Suginta, 2005, Enzymatic properties of wild-type and active site mutants of chitinase A from Vibrio carchariae, as revealed by HPLC-MS, FEBS J., 272, 3376, 10.1111/j.1742-4658.2005.04753.x Suginta, 2013, Molecular uptake of chitooligosaccharides through chitoporin from the marine bacterium Vibrio harveyi, PLoS One, 8, 10.1371/journal.pone.0055126 Suginta, 2013, Chitoporin from Vibrio harveyi, a channel with exceptional sugar specificity, J. Biol. Chem., 288, 11038, 10.1074/jbc.M113.454108 Macauley, 2010, Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes, Chem. Biol., 17, 937, 10.1016/j.chembiol.2010.07.006 Steiner, 2009, 2-Acetamino-1,2-dideoxynojirimycin-lysine hybrids as hexosaminidase inhibitors, Tetrahedron Asymmetry, 20, 832, 10.1016/j.tetasy.2009.02.015 Stubbs, 2009, A selective inhibitor Gal-PUGNAc of human lysosomal β-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells, Angew. Chem. Int. Ed., 48, 1300, 10.1002/anie.200804583 Maier, 2003, The X-ray crystal structure of human β-hexosaminidase B provides new insights into Sandhoff disease, J. Mol. Biol., 328, 669, 10.1016/S0022-2836(03)00311-5 Mark, 2003, Crystal structure of human β-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease, J. Mol. Biol., 327, 1093, 10.1016/S0022-2836(03)00216-X Liu, 2011, Active-pocket size differentiating insectile from bacterial chitinolytic β-N-acetyl-d-hexosaminidases, Biochem. J., 438, 467, 10.1042/BJ20110390 Whitworth, 2007, Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise, J. Am. Chem. Soc., 129, 635, 10.1021/ja065697o Doyle, 1997, Characterization of binding interactions by isothermal titration calorimetry, Curr. Opin. Biotechnol., 8, 31, 10.1016/S0958-1669(97)80154-1 Holdgate, 2005, Measurements of binding thermodynamics in drug discovery, Drug Discov. Today, 10, 1543, 10.1016/S1359-6446(05)03610-X Cooper, 2001, Heat does not come in different colours: entropy-enthalpy compensation, free energy windows, quantum confinement, pressure perturbation calorimetry, solvation and the multiple causes of heat capacity effects in biomolecular interactions, Biophys. Chem., 93, 215, 10.1016/S0301-4622(01)00222-8 Ohnuma, 2011, Chitin oligosaccharide binding to a family GH19 chitinase from the moss Bryum coronatum, FEBS J., 278, 3991, 10.1111/j.1742-4658.2011.08301.x